A Phase III multi center placebo controlled trial of Sorafenib BAY 43 9006 in patients with relapsed or refractory advanced predominantly non squamous Non Small Cell Lung Cancer NSCLC after 2 or 3 previous treatment regimens

Supported projects > Other Supported Projects · 2009

Authors: Tuncay GÖKSEL

2009-2010, Other Supported Projects, R & D Project, Completed

View details